Latest Insider Transactions at Inari Medical, Inc. (NARI)
This section provides a real-time view of insider transactions for Inari Medical, Inc. (NARI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Inari Medical, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Inari Medical, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 19
2021
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
9,000
-0.3%
|
$864,000
$96.6 P/Share
|
|
Jan 13
2021
|
Kirk G. Nielsen Director |
SELL
Other acquisition or disposition
|
Indirect |
1,082,364
-73.33%
|
-
|
|
Jan 13
2021
|
Kirk G. Nielsen Director |
BUY
Other acquisition or disposition
|
Direct |
11,933
+23.63%
|
-
|
|
Jan 13
2021
|
Kirk G. Nielsen Director |
BUY
Other acquisition or disposition
|
Indirect |
220,532
+50.0%
|
-
|
|
Jan 13
2021
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
27,600
-2.49%
|
$2,622,000
$95.66 P/Share
|
|
Jan 13
2021
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
36,000
-14.19%
|
$3,276,000
$91.23 P/Share
|
|
Jan 13
2021
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
36,000
+27.8%
|
$0
$0.46 P/Share
|
|
Jan 13
2021
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
30,000
-0.84%
|
$2,730,000
$91.22 P/Share
|
|
Jan 11
2021
|
Donald B Milder Director |
SELL
Open market or private sale
|
Indirect |
7,000
-0.05%
|
$588,000
$84.18 P/Share
|
|
Jan 08
2021
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-2.74%
|
$410,000
$82.87 P/Share
|
|
Jan 05
2021
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
27,600
-1.85%
|
$2,208,000
$80.44 P/Share
|
|
Jan 04
2021
|
Kirk G. Nielsen Director |
SELL
Other acquisition or disposition
|
Indirect |
1,082,362
-58.33%
|
-
|
|
Jan 04
2021
|
Kirk G. Nielsen Director |
BUY
Other acquisition or disposition
|
Direct |
11,932
+30.94%
|
-
|
|
Jan 04
2021
|
Kirk G. Nielsen Director |
BUY
Other acquisition or disposition
|
Indirect |
220,530
+50.0%
|
-
|
|
Jan 04
2021
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
100,000
-1.98%
|
$8,500,000
$85.17 P/Share
|
|
Dec 24
2020
|
Gilde Healthcare Iv U.A. Cooperatieve > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
39,068
-0.16%
|
$3,203,576
$82.16 P/Share
|
|
Dec 23
2020
|
Gilde Healthcare Iv U.A. Cooperatieve > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
265,768
-0.72%
|
$21,527,208
$81.84 P/Share
|
|
Dec 22
2020
|
Gilde Healthcare Iv U.A. Cooperatieve > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
284,022
-0.49%
|
$21,869,694
$77.11 P/Share
|
|
Dec 21
2020
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,500
-5.07%
|
$111,000
$74.0 P/Share
|
|
Dec 21
2020
|
Thomas Tu Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+4.82%
|
$0
$0.46 P/Share
|
|
Dec 21
2020
|
Gilde Healthcare Iv U.A. Cooperatieve > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
194,950
-0.59%
|
$14,036,400
$72.52 P/Share
|
|
Dec 18
2020
|
Gilde Healthcare Iv U.A. Cooperatieve > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
216,192
-1.05%
|
$15,349,632
$71.4 P/Share
|
|
Dec 18
2020
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
27,400
-2.47%
|
$1,918,000
$70.84 P/Share
|
|
Dec 11
2020
|
Gilde Healthcare Iv U.A. Cooperatieve > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
71,446
-0.51%
|
$4,715,436
$66.99 P/Share
|
|
Dec 10
2020
|
Donald B Milder Director |
SELL
Open market or private sale
|
Indirect |
7,000
-0.07%
|
$476,000
$68.01 P/Share
|
|
Dec 10
2020
|
Gilde Healthcare Iv U.A. Cooperatieve > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
136,043
-0.64%
|
$9,114,881
$67.69 P/Share
|
|
Dec 09
2020
|
Gilde Healthcare Iv U.A. Cooperatieve > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
155,224
-0.71%
|
$10,244,784
$66.65 P/Share
|
|
Dec 08
2020
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+7.41%
|
$0
$0.46 P/Share
|
|
Dec 08
2020
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-4.05%
|
$325,000
$65.11 P/Share
|
|
Dec 08
2020
|
Gilde Healthcare Iv U.A. Cooperatieve > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
28,677
-0.39%
|
$1,864,005
$65.35 P/Share
|
|
Dec 07
2020
|
Gilde Healthcare Iv U.A. Cooperatieve > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
70,939
-0.96%
|
$4,611,035
$65.1 P/Share
|
|
Dec 04
2020
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
30,000
-1.14%
|
$1,920,000
$64.54 P/Share
|
|
Dec 04
2020
|
Gilde Healthcare Iv U.A. Cooperatieve > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
14,482
-0.2%
|
$941,330
$65.01 P/Share
|
|
Dec 03
2020
|
Donald B Milder Director |
SELL
Bona fide gift
|
Indirect |
210,000
-4.2%
|
-
|
|
Dec 03
2020
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+46.51%
|
$0
$0.46 P/Share
|
|
Dec 03
2020
|
Gilde Healthcare Iv U.A. Cooperatieve > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,620
-0.02%
|
$105,300
$65.03 P/Share
|
|
Dec 02
2020
|
Kirk G. Nielsen Director |
SELL
Other acquisition or disposition
|
Indirect |
532,475
-43.72%
|
-
|
|
Dec 02
2020
|
Kirk G. Nielsen Director |
BUY
Other acquisition or disposition
|
Direct |
5,869
+28.52%
|
-
|
|
Dec 02
2020
|
Kirk G. Nielsen Director |
BUY
Other acquisition or disposition
|
Indirect |
108,490
+50.0%
|
-
|
|
Dec 02
2020
|
Gilde Healthcare Iv U.A. Cooperatieve > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
79,025
-0.26%
|
$5,057,600
$64.81 P/Share
|
|
Dec 01
2020
|
Gilde Healthcare Iv U.A. Cooperatieve > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
164,688
-0.72%
|
$11,198,784
$68.02 P/Share
|
|
Nov 30
2020
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,500
-2.87%
|
$234,500
$67.74 P/Share
|
|
Nov 30
2020
|
Thomas Tu Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+9.97%
|
$0
$0.46 P/Share
|
|
Nov 30
2020
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
27,400
-2.24%
|
$1,835,800
$67.37 P/Share
|
|
Nov 30
2020
|
Gilde Healthcare Iv U.A. Cooperatieve > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
199,216
-0.64%
|
$13,347,472
$67.32 P/Share
|
|
Nov 27
2020
|
Gilde Healthcare Iv U.A. Cooperatieve > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
78,640
-0.33%
|
$5,347,520
$68.07 P/Share
|
|
Nov 18
2020
|
Presidio Management Group X LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
20,000
-32.85%
|
$1,320,000
$66.38 P/Share
|
|
Nov 17
2020
|
Jonathan D Root Director |
BUY
Other acquisition or disposition
|
Direct |
81,996
+50.0%
|
-
|
|
Nov 17
2020
|
Jonathan D Root Director |
SELL
Other acquisition or disposition
|
Indirect |
2,905,296
-53.33%
|
-
|
|
Nov 17
2020
|
Jonathan D Root Director |
BUY
Other acquisition or disposition
|
Indirect |
587,851
+50.0%
|
-
|